Infusion Express Appoints Douglas Ghertner as Chief Executive Officer

National Operator of Ambulatory Infusion Centers to Pursue Aggressive Growth Strategy of its Concierge Approach to Complex Chronic Conditions

Kansas City, MO and Nashville, TN – (January 5, 2018)

Infusion Express, Inc., a leading national operator of ambulatory infusion centers serving patients with complex chronic conditions, and a portfolio company of Health Velocity Capital (HVC) and McKesson Ventures, today announced the appointment of Douglas Ghertner as Chief Executive Officer (CEO).

Ghertner brings over 20 years of healthcare experience to Infusion Express, including senior leadership positions at CVS Health, Change Healthcare and Emdeon. Most recently, Ghertner served as CEO of Change Healthcare, prior to its sale to Emdeon. Following the sale of Change Healthcare, Ghertner assumed the role of Executive Vice President and Chief Sales Officer, overseeing all sales and channel partner activity for the $1.5 billion healthcare technology and services provider. Ghertner holds a bachelor’s degree with special attainments in commerce from Washington and Lee University and a master’s degree in business administration from the University of Georgia. Ghertner succeeds founder Don Peterson as CEO. As part of the appointment to CEO, Ghertner is joining Infusion Express’ Board of Directors.

Ghertner commented, "I could not be more excited about the opportunity at Infusion Express as it touches on that rare intersection in healthcare of quantifiably lowering costs while improving the member/patient experience. With the additional capital from Health Velocity and McKesson Ventures, the Company is poised to expand the positive impact it can have on the lives of patients living with complex chronic conditions.”

“Since founding Infusion Express four years ago, the company has grown rapidly and now supports the needs of patients across a broad range of geographies,” said Infusion Express founder and former CEO Don Peterson. “The addition of Doug to our leadership team will lead us into our next phase of growth and enable the company to accelerate the pace with which we deliver our consumer-centric, patient- first model to additional communities.” Peterson will continue to serve Infusion Express as its President and as a member of its leadership team.

Martin Felsenthal, Partner at HVC, remarked, “HVC has committed significant capital to Infusion Express to execute on its exciting growth strategy. Having worked with Doug at Change Healthcare, we believe the leadership team we are assembling will enable Infusion Express to continue its expansion and capitalize on the many opportunities before it. On behalf of the company and the board of directors, we are incredibly grateful for Don Peterson’s stewardship and execution of the company’s vision over the last four years and excited for his continued role in the company’s future success.”

“Our team is proud to support innovative companies, like Infusion Express, who achieve health care’s triple aim of improving patient experience, the health of populations and reducing per capita cost of health care,” said Dave Schulte, Managing Director at McKesson Ventures. “Expanding the leadership team will enable Infusion Express to grow even faster and offer their superior service to more patients across the nation.”

###

About Infusion Express, Inc.

IVX offers a new approach to IV treatments that combines extreme customer care with low-cost and efficient delivery of expensive biologics and other essential treatments. The company’s superior patient experience together with a technology-based approach to medication adherence and chronic disease management benefits payers and providers as well as patients and their families.

About Health Velocity Capital

Health Velocity Capital has offices in San Francisco, CA, and Nashville, TN, and invests exclusively in innovative healthcare software and services companies.  The firm’s partners have more than 50 collective years of experience investing, building and managing as investors, entrepreneurs and senior executives, innovative companies that created important new healthcare markets and/or that became market leaders.  In addition to investing on behalf of institutional investors, Health Velocity invests on behalf of a number of our nation’s largest and most influential healthcare organizations and a number of current and former healthcare senior executives and leaders.  Collectively, these investors represent organizations that provide health insurance to more than 60 million Americans, operate more than 80 hospitals, provide pharmacy and PBM services to more than 75% of all Americans, and provide software and services to every major hospital in the United States.  For more information, please visit www.healthvelocitycapital.com.

About McKesson Ventures

McKesson Ventures is the venture capital arm of McKesson Corporation specializing in early and growth stage companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. health care landscape. McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a health care services and information technology company dedicated to making the business of health care run better. We work with payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and others across the spectrum of care to build healthier organizations that help deliver better care to patients in every setting. Visit www.mckessonventures.com to learn more.